Getty Images As the deadline for filing federal income taxes nears, have you thought about how you can cut money, time or frustration in how you file your return? The Internal Revenue Service's Free File allows for a no-cost federal return if your household's 2013 adjusted gross income was $58,000 or less. You can use its online fillable forms or brand-name tax software by selecting a service provider to file listed on the site. Depending on which state you live in, you may need to pay for your state return. Some "e-file partner" companies provide free state returns; check the company's website. Regardless of whether you meet the $58,000 limit, these providers offer many free federal filing options. 1040EZ forms are offered for free preparation and filing by e-Smart Tax and TaxSlayer. TaxACT has a variety of IRS tax forms and schedules for free preparation and filing. Basic IRS forms can be prepared and filed for free with TurboTax, which will import W-2 information, so tax filing requires less time to complete. State returns may have a fee to file, and more complex federal forms can bring additional costs. IRS-certified volunteers offer free help for taxpayers who qualify. Volunteer Income Tax Assistance covers electronic filing for those who meet the $52,000 or less threshold. People 60 years old and older can get help with taxes -- and issues related to pension and retirement -- through the Tax Counseling for the Elderly Program. Active duty members of the military can use TaxSlayer's free federal version.
Top 5 Construction Material Stocks To Watch For 2015: Trinseo S.A. (TSE)
Trinseo S.A. (Trinseo), incorporated on June 3, 2010, is a materials company engaged in the manufacture and marketing of specialty and customized emulsion polymers and plastics. The Company develops products for global, diversified end markets, including coated paper and packaging board, carpet and artificial turf backing, automotive applications, including tires, food service packaging, appliances, consumer electronics and construction applications, among others. The Company operates under two principal business units: Emulsion Polymers business unit, which includes an Synthetic Rubber (SB) Latex segment and a SB segment, and Plastics business unit, which includes Styrenics segment and an Engineered Polymers segment. Trinseo�� major products include styrene-butadiene latex (SB latex), styrene-acrylate latex (SA latex), solution styrene-butadiene rubber (SSBR), lithium polybutadiene rubber (Li-PBR), emulsion styrene-butadiene rubber (ESBR), nickel polybutadiene rubber (Ni-PBR), polystyrene, expandable polystyrene (EPS), acrylonitrile-butadiene-styrene (ABS), styrene-acrylonitrile (SAN), ignition resistant polystyrene, polycarbonate resins (PC), compounds and blends, and polypropylene compounds.
Synthetic Rubber (SB) Latex Segment
The Company produce SB latex primarily for coated paper used in advertising and magazines, packaging board coatings, carpet and artificial turf backings, as well as a number of performance latex applications. It operates in various countries, such as North America, Europe and Asia.
Synthetic Rubber Segment
The Company is a producer of styrene-butadiene and polybutadiene-based rubber products. The Company has synthetic rubber technology and product portfolios, which focuses on specialty products, such as SSBR and Li-PBR, while also producing core products, such as ESBR and Ni-PBR. Its Synthetic Rubber products are extensively used in tires, with additional applications, including polymer modification and technical rubbe! r goods.
Styrenics Segment
The Company�� Styrenics segment includes polystyrene, ABS, SAN, and EPS products, as well as its internal production and sourcing of styrene monomer, a raw material common in SB latex, synthetic rubber and styrenics products. It is a producer of polystyrene and mass ABS (mABS). Trinseo focuses its marketing efforts on applications, such as appliances and consumer electronics. The Styrenics segment also serves the packaging and construction end-use markets.
Engineered Polymers Segment
The Company is a producer of engineered polymers. Its products are used in automotive, consumer electronics, and construction and sheet end markets. Trinseo focuses on differentiated products, which it produces in its compounds and blends manufacturing facilities located across Europe, Asia, North America and Brazil. Its Engineered Polymers segment also compounds and blends its polycarbonate resins and mABS plastics into differentiated products within these sectors.
The Company competes with BASF, Nippon Zeon, LG Chemicals and Bayer.
Advisors' Opinion:- [By Vanina Egea]
Gary Dickerson is following a similar acquisitions strategy to the one it had used at Varian Semiconductor in 2012. The company is currently on the process (presumably closed by second mid-term of 2014) of merging with Tokyo Electron Device Ltd. (TSE) (11% of the market share), one of the three big names in the industry. This will create a new company worth $29 billion. Combined with the 14% market share of Applied Materials, this new company would capture the biggest slice of the market share, and the broad product portfolio of both companies ensures the coverage of many segments of the market. The new company would use Tokyo Electron's material supplies to improve its costs.
Top 10 Dow Dividend Stocks To Watch Right Now: Lucara Diamond Corp (LUCRF.PK)
Lucara Diamond Corp. (Lucara) is a diamond development company focused in Africa. The business of Lucara consists of the acquisition, exploration and development of diamond properties. The principal assets of Lucara and the focus of Lucara�� development and exploration activities are its interest in mining, exploration and prospecting diamond licenses in Lesotho, Botswana and Namibia. The Company�� project Mothae Diamond Project is located in northeast Lesotho. In May 2010, it commenced test mining in Mothae Diamond Project-Lesotho. Mothae Diamonds (PTY) Ltd (Mothae Diamonds), an indirect 75% owned subsidiary of the Company, holds a 100% interest in the Mothae project. As of March 23, 2011, a total of 175,000 dry tons had been processed from the C domain, producing 5,484 carats at an average grade of 3.13 carats per hundred tons. In December 2010, the Company completed the acquisition of African Diamonds PLC, upon which Lucara indirectly owns 100% of the AK6 Diamond Project. Advisors' Opinion:- [By John Leonard]
Lucara Diamond (LUCRF.PK) is still being valued as a riskier exploration stage miner rather than a profitable and growing producer. The current "backward looking" valuation fails to reflect the recent and significant operational transition.
Top 10 Dow Dividend Stocks To Watch Right Now: H&R Block Inc. (HRB)
H&R Block, Inc., through its subsidiaries, provides tax preparation, retail banking, and various business advisory and consulting services. It operates in three segments: Tax Services, Business Services, and Corporate. The Tax Services segment offers H&R Block At Home, an income tax preparation software, as well as a range of online tax services, including tax advice, professional and do-it-yourself tax return preparation, and electronic filing services through its Web site at hrblock.com primarily in the United States, Canada, and Australia. This segment also provides the H&R Block Prepaid Emerald MasterCard and Emerald Advance lines of credit through H&R Block Bank, as well as other retail banking services, including checking and savings accounts, individual retirement accounts, and certificates of deposit; and sells refund anticipation loans and refund anticipation checks offered by third-party lending institutions, as well as offers income tax return preparation course s to the public. The Business Services segment provides tax and consulting services, wealth management, and capital markets services to middle-market companies. The Corporate segment engages in various operations, which include interest income from the United States passive investments, interest expense on borrowings, net interest margin and gains or losses relating to mortgage loans held for investment, real estate owned, residual interests in securitizations and other corporate expenses principally related to finance, legal, and other support departments. The company was founded in 1946 and is headquartered in Kansas City, Missouri.
Advisors' Opinion:- [By Ben Rooney]
In corporate news, shares of H&R Block (HRB) jumped after the company said it will sell its bank to Bofl Federal Bank. Shares of retailer GAP (GPS, Fortune 500) slid when the company said sales fell in March.
Top 10 Dow Dividend Stocks To Watch Right Now: GTT Communications Inc (GTT)
GTT Communications, Inc., formerly Global Telecom & Technology, Inc., incorporated on January 3, 2005, is a global network integrator providing a portfolio of Wide-Area Network (WAN), dedicated Internet access and managed data services. The Company combines multiple networks and technologies, such as traditional OC-x, MPLS and Ethernet, to deliver solutions designed for each client�� requirements. The Company improves its client performance through its Client Management Database (CMD), providing customers with an integrated support system for all of their services. It is provides solutions, project management and 24x7 global operations support. In May 2012, the Company acquired nLayer Communications Inc. In April 2013, Neutral Tandem Inc acquired the global data services business of Global Telecom & Technology Inc.
The Company�� global operations consist of two parts: global customer operations, and global network operations and engineering. Customer operations include project management and development of its CMD system. Global project management assures the implementation of a customer services after the sale. Network operations and engineering consists of global Network Operations Center (NOC) and Engineering and Information and Communications Technology (ICT). The NOC receives, prioritizes, tracks and resolves network outages or other customer needs, along with provisioning and testing of services. Engineering provides support for the NOC and the sales team, as well as carrying out all provisioning for GTT Network Services. ICT manages all internal desktop, and network and server infrastructure.
The Company competes with Level 3, Qwest, KPN, XO Communications, COLT, Verizon Business, AT&T, British Telecom, NTT and Deutsche Telekom.
Advisors' Opinion:- [By The GeoTeam]
This brings us to Global Telecom (GTT), a company that provides customers with innovative connectivity solutions by utilizing its own network assets.
Top 10 Dow Dividend Stocks To Watch Right Now: Protalix Biotherapeutics Inc (PLX)
Protalix BioTherapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system, ProCellEx. Using its ProCellEx system, the Company is developing a pipeline of biosimilar or generic versions of recombinant therapeutic proteins based on its plant cell-based expression technology, which focuses pharmaceutical markets and that rely upon known biological mechanisms of action. ProCellEx protein expression system consists of a set of technologies and capabilities for the development of recombinant proteins, including advanced genetic engineering technology and plant cell-based protein expression methods. Its ProCellEx protein expression system is built on flexible custom-designed bioreactors made of polyethylene and optimized for the development of complex proteins in plant cell cultures. In June 2010, it had completed the preliminary phase I clinical trial of PRX-105.
Taliglucerase Alfa
Taliglucerase alfa is a plant cell expressed recombinant glucocerebrosidase enzyme (GCD) for the treatment of Gaucher disease. The Company has commenced pre-clinical studies of an oral form of taliglucerase alfa. Its oral taliglucerase alfa is a plant cell expressed form of GCD that is naturally encapsulated within carrot cells genetically engineered to express the GCD enzyme. Pre-clinical studies of oral taliglucerase alfa demonstrate the stability of the enzyme in the cell and the capacity of the cell�� cellulose wall to protect the enzyme against degradation in the digestive tract in an in-vitro model of the stomach and intestines. Additionally, rats fed with lyophilized carrot cells expressing GCD have accumulated the active enzyme in the target organs; the spleen and liver. As of December 31, 2010, the Company had completed Phase III Clinical Trial.
PRX-102
The Company is developing PRX-102, its plant cell expressed modified version of the recombinant ! alpha-GAL-A protein, a therapeutic enzyme for the treatment of Fabry disease. Fabry disease is a rare, hereditary, genetic lysosomal storage disorder in humans caused by an X-lined deficiency of the alpha-GAL-A enzyme. The Company is in the animal evaluation testing phase of the development of PRX-102, which tests are based on a mouse model for Fabry disease.
Acetylcholinesterase
Protalix Ltd. is a wholly owned subsidiary of the Company is licensed the rights to certain technology under a research and license agreement with Yissum Research and Development Company (Yissum) and the Boyce Thompson Institute, Inc. Pursuant to the agreement, the Company is developing PRX-105, a plant cell-based acetylcholinesterase (AChE) and its molecular variants for the use in several therapeutic and prophylactic indications, as well as in a biodefense program and an organophosphate-based pesticide treatment program.
As of December 31, 2010, its in-vitro experiments of PRX-105 have shown that the acetylcholinesterase enzyme in its ProCellEx protein expression system demonstrates biological activity on biochemical and cellular levels. In addition, early animal studies demonstrated that the acetylcholinesterase expressed in its ProCellEx protein expression system was able to treat animals exposed to the nerve gas agent analogues, both when injected with its acetylcholinesterase product candidate immediately before exposure or when injected after exposure. In March 2010, it initiated a preliminary phase I clinical trial of PRX-105, which the Company completed in June 2010.
pr-antiTNF
pr-antiTNF is a candidate for the treatment of certain autoimmune diseases such as rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing, spondylitis, psoriatic arthritis and plaque psoriasis. The Company has designed the antiTNF as pr-antiTNF. pr-antiTNF is a plant cell-expressed recombinant fusion protein made from the soluble form of the human TNF receptor (TNFR), f! used to t! he Fc component of a human antibody domain. pr-antiTNF has an identical amino acid sequence to Enbrel and its in-vitro and preclinical animal studies have demonstrated that pr-antiTNF exhibits similar activity to Enbrel. Specifically, pr-antiTNF binds TNF thereby inhibiting it from binding to cellular surface TNF receptors and protects L929 cells from TNF-induced apoptosis in a dose-dependent manner.
The Company competes with Genzyme, Actelion, Crucell N.V., Biolex, Inc., Chlorogen, Inc., Greenovation Biotech GmbH, Symbiosys, Novartis AG/Sandoz Pharmaceuticals, BioGeneriX AG, Stada Arzneimittel AG, BioPartners GmbH and Teva.
Advisors' Opinion:- [By Keith Speights]
Other investors might wish that Pfizer would use some of its cash to acquire a few smaller companies. Protalix BioTherapeutics (NYSEMKT: PLX ) has been mentioned as one possible candidate. The two companies already partner together on Gaucher disease drug Elelyso. In February, Protalix spurred rumors that Pfizer could be interested in buying the company after it announced that it had engaged Citigroup to pursue a "broad array of strategic alternatives."
- [By Maxx Chatsko]
Industrial biotech isn't the only industry headed to Brazil. Protalix (NYSEMKT: PLX ) entered into a technology transfer agreement with Brazil's Ministry of Health last week that will pay the company $280 million. The deal is big news for Protalix's first product, Elelyso/Uplyso, which was developed with partner Pfizer (NYSE: PFE ) . The treatment is approved as an enzyme replacement therapy, or ERT, for adults with type 1 Gaucher disease, and it marks a huge step forward for the future of biomanufacturing. In the following video, Fool contributor Maxx Chatsko explains what this means for the product's commercialization and the adoption of Protalix's novel plant cell-based expression system for therapeutic proteins.
Top 10 Dow Dividend Stocks To Watch Right Now: Gildan Activewear Inc.(GIL)
Gildan Activewear Inc. engages in the manufacture and sale of apparel products primarily in the United States, Canada, and Europe. It sells T-shirts, fleece, and sport shirts to wholesale distributors under the Gildan brand name. The company also provides its activewear products for work and school uniforms and athletic team wear, and other purposes to convey individual, group, and team identity. In addition, it offers undecorated products to branded apparel companies and retailers; and underwear products. Further, the company markets its sock products under the various brands, including Gold Toe, PowerSox, SilverToe, Auro, All Pro, GT, and the Gildan brand. The company was formerly known as Textiles Gildan Inc. and changed its name to Gildan Activewear Inc. in March 1995. Gildan Activewear Inc. was founded in 1984 and is headquartered in Montreal, Canada.
Advisors' Opinion:- [By Eric Volkman]
Gildan Activewear (NYSE: GIL ) just bought itself a new wardrobe. The company announced it has acquired "substantially all of the assets" of privately held screen printing and apparel decoration specialist New Buffalo Shirt Factory for around $7 million.
- [By Tom Stoukas]
Deutsche Lufthansa AG (LHA) and Allianz SE (ALV) led airlines and insurers lower, retreating at least 1.5 percent. Bayerische Motoren Werke AG (BMW) slid 1.6 percent. Deutsche Bank AG (DBK) rose after JPMorgan Chase & Co. boosted its recommendation on the shares. Gildemeister AG (GIL) added 3.4 percent after Deutsche Bank upgraded the maker of cutting tools.
Top 10 Dow Dividend Stocks To Watch Right Now: Art's-Way Manufacturing Co. Inc.(ARTW)
Art?s-Way Manufacturing Co., Inc., together with its subsidiaries, engages in the manufacture and sale of agricultural equipment in the United States. It offers portable and stationary animal feed processing equipment and related attachments used to mill and mix feed grains into custom animal feed rations; a crop production line that includes grain drill equipment; hay and forage equipment consisting of forage boxes, forage blowers, running gears, dump boxes, rotary rakes, finger wheel rakes, and mergers; stalk shredders; portable grain augers; manure spreaders; sugar beet harvesting equipment; land maintenance equipment; and moldboard plows, as well as provides hay blowers to original equipment manufacturers. The company also manufactures and supplies pressure steel vessels and steel containment systems for water treatment, air receivers, refineries, co-generation, chemical, petrochemical, storage tanks, agriculture, marine, refrigeration, hydro pneumatic, heavy equipmen t, pharmaceuticals, and mining industries. In addition, it provides services, such as custom CAD drawing; welding; interior linings and exterior finishing; passivation of stainless steel; hydrostatic and pneumatic testing; design, build and finishing of skids; installation of piping; and non-destructive examination and heat treating, as well as offers after-market service parts. Further, the company produces and sells modular buildings that are used for animal containment and research laboratories. Art?s-Way Manufacturing Co., Inc. sells its products through independent farm equipment dealers primarily under the Art?s-Way, Miller Pro, and Badger brand names. The company was founded in 1956 and is based in Armstrong, Iowa.
Advisors' Opinion:- [By Monica Gerson]
Art's-Way Manufacturing Co (NASDAQ: ARTW) is estimated to post its quarterly earnings.
Packaging Corporation of America (NYSE: PKG) is projected to post its Q3 earnings at $0.89 per share on revenue of $831.79 million.
No comments:
Post a Comment